NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2020, Vol. 32 ›› Issue (增刊2): 86-92.

Previous Articles     Next Articles

Three dimensional quantitative structure activity relationship of B-Raf (V600E) kinase ⅡB inhibitor

ZHANG Cong-cong1,ZHANG Wen2,LONG Ying-ting1,XIE Hui-ding1,QIU Kai-xiong1*#br#

#br#
  

  1. 1School of Pharmacy,Kunming Medical University,Kunming 650500,China; 2The Third People′s Hospital of Gansu Province,Lanzhou 730000,China

  • Online:2020-12-09 Published:2020-12-09

Abstract:

To realize the virtual filtering of B-Raf (V600E) kinase IIB-type inhibitors and provide an important research basis for the development of novel anticancer drugs.We use comparative molecular similarity index analysis (CoMSIA) to study a series of B-Raf (V600E) kinase IIB-type inhibitors in three-dimensional quantitative structure-activity relationship,and the three-dimensional equipotential diagram of the obtained CoMSIA model was analyzed.The experimental results show that the cross validation coefficient of CoMSIA model q2 = 0.406,and the non cross validation coefficient of CoMSIA model r2ncv= 0.996.The results suggested that increasing the volume of groups in pyrimidine ring and decreasing the electronegativity of groups in benzene ring are beneficial to the improvement of activity,amino (-NH2) and imino (-NH) in the molecule are hydrogen bond donor groups,carbonyl (>C=O) and sulfonyl (-SO2-) are hydrogen bond receptor groups,which are the key active groups,and nitrogen atom in pyridine ring will reduce the activity of the compound.

Key words: B-Raf (V600E) kinase IIB-type inhibitor, comparative molecular similarity index analysis, structural modification, pharmacophore model

CLC Number: